# EDGAR Filing Document

**Accession Number:** 0001227636
**File Stem:** 0000921895-26-001483
**Filing Date:** 2026-5
**Character Count:** 6827
**Document Hash:** 83f681cda355e4b4ca77af85aa5105df
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000921895-26-001483.hdr.sgml**: 20260527

**ACCESSION NUMBER**: 0000921895-26-001483

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260527

**DATE AS OF CHANGE**: 20260527

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Neuronetics, Inc.
- **CENTRAL INDEX KEY:** 0001227636
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-90797
- **FILM NUMBER:** 261022927

**BUSINESS ADDRESS:**
- **STREET 1:** 3222 PHOENIXVILLE PIKE
- **CITY:** MALVERN
- **STATE:** PA
- **ZIP:** 19355
- **BUSINESS PHONE:** 877-600-7555

**MAIL ADDRESS:**
- **STREET 1:** 3222 PHOENIXVILLE PIKE
- **CITY:** MALVERN
- **STATE:** PA
- **ZIP:** 19355

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NEURONETICS INC
- **DATE OF NAME CHANGE:** 20030416
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Chernett Jorey
- **CENTRAL INDEX KEY:** 0002042077

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**MAIL ADDRESS:**
- **STREET 1:** 6222 INDIANWOOD TR.
- **CITY:** BLOOMFIELD HILLS
- **STATE:** MI
- **ZIP:** 48301

## Ex-1

Exhibit 1

**<u>Transactions in the Securities of the Issuer Since the Filing of Amendment No. 2 to the Schedule 13D</u>**

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp; Shares of Common Stock<br> <u>Purchased/(Sold)</u> | &nbsp;&nbsp; Price Per<br> <u>Share ($)<sup>1</sup></u> | &nbsp;&nbsp; Date of<br> <u>Purchase / Sale</u> |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;100,000 | &nbsp;&nbsp;1.58 | &nbsp;&nbsp;4/20/2026 |
| &nbsp;&nbsp;100,000 | &nbsp;&nbsp;1.51 | &nbsp;&nbsp;4/21/2026 |
| &nbsp;&nbsp;475,000 | &nbsp;&nbsp;1.34 | &nbsp;&nbsp;5/12/2026 |
| &nbsp;&nbsp;100,000 | &nbsp;&nbsp;1.17 | &nbsp;&nbsp;5/19/2026 |

---

<sup>1</sup> The prices reported in this column are weighted average prices. The Reporting Person undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased (or sold) at each separate price such shares were purchased.

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 2)**

**Neuronetics, Inc.**

*(Name of Issuer)*

**Common Stock, $0.01 par value**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**Jorey Chernett**<br>6222 Indianwood Tr.<br>Bloomfield Hills MI 48301<br>(248) 469-8811

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**05/19/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Chernett Jorey** | Name of reporting person<br>**Chernett Jorey** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**10553988.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**10553988.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**10553988.00** | Aggregate amount beneficially owned by each reporting person<br>**10553988.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**15.17%** | Percent of class represented by amount in Row (11)<br>**15.17%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, $0.01 par value

**(b) Name of Issuer:**
Neuronetics, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
3222 PHOENIXVILLE PIKE, MALVERN, PA, 19355

This Amendment No. 2 to Schedule 13D ("Amendment No. 2") amends and supplements the Schedule 13D initially filed by the Reporting Person on March 31, 2026 (the "Original Schedule 13D") with respect to the Shares. Except as specifically amended and supplemented hereby, the Original Schedule 13D remains in full force and effect. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Original Schedule 13D.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The aggregate percentage of Shares beneficially owned by the Reporting Person is based upon 69,587,840 Shares outstanding as of May 1, 2026, as disclosed in the Issuer's Quarterly Report on Form 10-Q, filed with the U.S. Securities and Exchange Commission (the "SEC") on May 5, 2026.

As of the close of business on May 26, 2026, the Reporting Person beneficially owned 10,553,988 Shares.

Percentage: Approximately 15.17%

**(b)**
1. Sole power to vote or direct vote: 10,553,988
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 10,553,988
4. Shared power to dispose or direct the disposition: 0

**(c)**
The transactions in the Shares by the Reporting Person since the filing of Amendment No. 1 to the Schedule 13D are set forth in more detail in Exhibit 1 attached hereto.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Chernett Jorey

**Signature:** /s/ Jorey Chernett

**Name/Title:** Jorey Chernett

**Date:** 05/27/2026